TY - STD TI - Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W. Sentinel lymph node biopsy melanoma patients with clinically negative regional lymphin melanoma patients with clinically negative regional lymph nodes--one institution’s experience. Melanoma Res. 2003;13(1):35–43. ID - ref1 ER - TY - STD TI - Vuylsteke RJ, van Leeuwen PA, Statius Muller MG, Gietema HA, Kragt DR, Meijer S. Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results. J Clin Oncol. 2003;21(6):1057–65. ID - ref2 ER - TY - STD TI - Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng CH, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17(3):976–83. ID - ref3 ER - TY - JOUR AU - Thompson, J. F. AU - Shaw, H. M. PY - 2007 DA - 2007// TI - Sentinel node mapping for melanoma: results of trials and current applications JO - Surg Oncol Clin N Am VL - 16 UR - https://doi.org/10.1016/j.soc.2006.10.013 DO - 10.1016/j.soc.2006.10.013 ID - Thompson2007 ER - TY - STD TI - Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127(4):392–9. ID - ref5 ER - TY - STD TI - Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19(16):3635–48. ID - ref6 ER - TY - STD TI - Balch CM, Soong SJ, Gershenwald JE, Thompson, JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19(16):3622–34. ID - ref7 ER - TY - STD TI - Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599–609. ID - ref8 ER - TY - STD TI - Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199–206. ID - ref9 ER - TY - JOUR AU - Karakousis, C. P. PY - 1998 DA - 1998// TI - Therapeutic node dissections in malignant melanoma JO - Ann Surg Oncol VL - 5 UR - https://doi.org/10.1007/BF02303638 DO - 10.1007/BF02303638 ID - Karakousis1998 ER - TY - STD TI - Eggermont AM, Suciu S, MacKie R, Ruka W, Testori A, Kruit W, et al. Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial. Lancet. 2005;366(9492):1189–96. ID - ref11 ER - TY - JOUR AU - Eggermont, A. M. AU - Gore, M. PY - 2007 DA - 2007// TI - Randomized adjuvant therapy trials in melanoma: surgical and systemic JO - Semin Oncol VL - 34 UR - https://doi.org/10.1053/j.seminoncol.2007.09.003 DO - 10.1053/j.seminoncol.2007.09.003 ID - Eggermont2007 ER - TY - STD TI - van Akkooi AC, Nowecki ZI, Voit C, Schafer-Hesterberg G, Michej W, de Wilt JH, et al. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes. Ann Surg. 2008;248(6):949–55. ID - ref13 ER - TY - STD TI - van Akkooi AC, de Wilt JH, Verhoef C, Schmitz PI, van Geel AN, Eggermont AM, et al. Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol. 2006;17(10):1578–85. ID - ref14 ER - TY - STD TI - Beger J, Hansel G, Kronert C, Fuchs M, Tanner C, Schonlebe J, et al. A 10-year analysis of primary cutaneous malignant melanoma with sentinel lymph node biopsy and long-term follow-up. Int J Dermatol. 2013;52(2):220–30. ID - ref15 ER - TY - STD TI - Thompson JF, Soong SJ, Balch CM, Gershenwald JE, Ding S, Coit DG, et al. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol. 2011;29(16):2199–205. ID - ref16 ER - TY - JOUR AU - Nowecki, Z. I. AU - Rutkowski, P. AU - Michej, W. PY - 2008 DA - 2008// TI - The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3) JO - Ann Surg Oncol VL - 15 UR - https://doi.org/10.1245/s10434-008-9965-3 DO - 10.1245/s10434-008-9965-3 ID - Nowecki2008 ER - TY - STD TI - Balch CM, Gershenwald JE, Soong SJ, Thompson, JF, Ding S, Byrd DR, et al. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol. 2010;28(14):2452–9. ID - ref18 ER - TY - STD TI - Wong SL, Kattan MW, McMasters KM, Coit DG. A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system. Ann Surg Oncol. 2005;12(4):282–8. ID - ref19 ER - TY - STD TI - White RL, Jr Ayers GD, Stell VH, Ding S, Gershenwald JE, Salo JC, et al. Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database. Ann Surg Oncol. 2011;18(13):3593–600. ID - ref20 ER - TY - STD TI - Balch CM, Thompson JF, Gershenwald JE, Soong SJ, Ding S, McMasters KM, et al. Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients. Ann Surg Oncol. 2014;21(4):1075–81. ID - ref21 ER - TY - STD TI - Wong SL, Balch CM, Hurley P, Agarwala SS, Akhurst TJ, Cochran A, et al. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. J Clin Oncol. 2012;30(23):2912–8. ID - ref22 ER - TY - STD TI - Mozzillo N, Pennacchioli E, Gandini S, Caraco C, Crispo A, Botti G, et al. Sentinel node biopsy in thin and thick melanoma. Ann Surg Oncol. 2013;20(8):2780–6. ID - ref23 ER - TY - STD TI - Testori A, De Salvo GL, Montesco MC, Trifiro G, Mocellin S, Landi G, et al. Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI). Ann Surg Oncol. 2009;16(7):2018–27. ID - ref24 ER - TY - STD TI - Ghaferi AA, Wong SL, Johnson TM, Lowe L, Chang AE, Cimmino VM, et al. Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma. Ann Surg Oncol. 2009;16(11):2978–84. ID - ref25 ER - TY - STD TI - Jakub JW, Huebner M, Shivers S, Nobo C, Puleo C, Harmsen WS, et al. The number of lymph nodes involved with metastatic disease does not affect outcome in melanoma patients as long as all disease is confined to the sentinel lymph node. Ann Surg Oncol. 2009;16(8):2245–51. ID - ref26 ER - TY - STD TI - van der Ploeg AP, van Akkooi AC, Haydu LE, Scolyer RA, Murali R, Verhoef C, et al. The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients. Eur J Cancer. 2014;50(1):111–20. ID - ref27 ER - TY - STD TI - Pasquali S, Mocellin S, Mozzillo N, Maurichi A, Quaglino P, Borgognoni L, et al. Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study. J Clin Oncol. 2014;32(9):935–41. ID - ref28 ER - TY - STD TI - Gershenwald JE, Andtbacka RH, Prieto VG, Johnson MM, Diwan AH, Lee JE, et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol. 2008;26(26):4296–303. ID - ref29 ER - TY - STD TI - Govindarajan A, Ghazarian DM, McCready DR,Leong WL. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse. Ann Surg Oncol. 2007;14(2):906–12. ID - ref30 ER - TY - STD TI - Wevers KP, Murali R, Bastiaannet E, Scolyer RA, Suurmeijer AJ, Thompson JF, et al. Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients. Eur J Surg Oncol. 2013;39(2):179–84. ID - ref31 ER - TY - JOUR AU - Nagaraja, V. AU - Eslick, G. D. PY - 2013 DA - 2013// TI - Is complete lymph node dissection after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? A meta-analysis JO - Eur J Surg Oncol VL - 39 UR - https://doi.org/10.1016/j.ejso.2013.02.022 DO - 10.1016/j.ejso.2013.02.022 ID - Nagaraja2013 ER -